Yulei Wang
From the Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA, Los Angeles (R.S.F.), the City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte (D.L.), and Genentech, South San Francisco (W.V., S.H., Y.W.) — all in California; the People’s Liberation Army Cancer Center, Jinling Hospital, Nanjing (S.Q.), and Roche Product Development (D.-Z.X., J.L., C.H.) and Jiahui International Cancer Center, Jiahui Health (A.X.Z.), Shanghai — all in China; National Cancer...
ORCID: 0000-0002-9057-9786Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma”.
Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more
Yulei Wang, Alireza Heravi-Moussavi, Ashley K. Koegel, Yojiro Kotake, Gavin D. Grant +19 more
Yulei Wang, Alireza Heravi-Moussavi, Ashley K. Koegel, Yojiro Kotake, Gavin D. Grant +17 more
Junyan Tao, Silvia Liu, Théo Z. Hirsch, Tyler M. Yasaka, Catherine Cao +13 more
Brandon M. Lehrich, Evan R. Delgado, Tyler M. Yasaka, Silvia Liu, Catherine Cao +29 more
Evan R. Delgado, Tyler M. Yasaka, Silvia Liu, Catherine Cao, Y. Liu +30 more